I would say that NBIX is one of the more interesting plays right now. There are very few groups out there with potential blockbuster in Phase 3 that is partnered with a world-class player. The uterine fibroids program is really interesting and I'm personally expected that we'll be acquired if it's positive. The VMAT program is just background noise right now. I'm personally not that excited about it. CNS is full of failures regardless of method of action. If the uterine fibroids is positive then I think Abbott will just lock up the assets and be done with this collaboration. There are very few companies sitting on an asset as valuable as elagolix.